Learn More
Medchemexpress LLC 4-fluoro-3-[(4-hydroxy-1-piperidinyl)sulfonyl]-N-(3,4,5-trifluorophenyl)-benzamide | 1445790-55-5 | 99.9% | 432.39 g·mol⁻¹ | C18H16F4N2O4S | 10MG

Supplier: Medchemexpress LLC HY12460010MG
NVR 3-778 is a first-in-class, orally bioavailable hepatitis B virus (HBV) capsid assembly modulator of the sulfamoylbenzamide class. It inhibits HBV capsid assembly and viral replication, shows pan-genotypic antiviral activity in preclinical models, and has advanced into clinical evaluation. Supplied as a high-purity research-grade compound for in vitro and in vivo HBV studies.
- High purity (99.9%).
- Orally bioavailable in preclinical models.
- Pan-genotypic antiviral activity against HBV.
- Mechanism: capsid assembly modulation.
- Available in multiple small pack sizes for research flexibility.
- Stable as powder at -20°C for up to 3 years.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.